Sort
39,280 grants matching “leukemia”
A Proteogenomic Analysis of Platelets in Patients with *
$597,940David J Kuter · Massachusetts General Hospital · R01 · FY2006 · HL
NMR Studies of Retroviral Nucleic Acid Binding Proteins
$597,858Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2011 · GM
NMR Studies of Retroviral Nucleic Acid Binding Proteins
$597,821Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2012 · GM
Combination Therapy in B-Chronic Lymphocytic Leukemia
$597,549Neil E Kay · Mayo Clinic Rochester · R01 · FY2008 · CA
The role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppression
$597,546Shan Zha · Columbia University Health Sciences · R01 · FY2022 · CA
Telomerase in Development, Senescence and Neoplasia
$597,518Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Molecular Epidemiology of NHL and CLL
$597,475James R Cerhan · Mayo Clinic Rochester · R01 · FY2009 · CA
Discovery and Optimization of AML Prognostic Biomarkers
$597,296Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia
$597,219Smita Bhatia · University Of Alabama At Birmingham · R01 · FY2018 · CA
Targeting B7-H3 in ovarian cancer
$597,170Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$597,140Shan Zha · Columbia University Health Sciences · R01 · FY2022 · CA
Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Progn
$597,111Fred R Hirsch · University Of Colorado Denver · U01 · FY2015 · CA
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
$597,078James Versalovic · Baylor College Of Medicine · U01 · FY2014 · CA
Defining the scope and clinical impact of donor CHIP after allogeneic HCT
$597,028Robert Coleman Lindsley · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Development of a Phenotype-based Predictive Analytic for Acute Myeloid Leukemia
$597,007Michael R Savona · Vanderbilt University Medical Center · R01 · FY2021 · CA
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
$596,963Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
$596,917Uttiya Basu · Columbia University Health Sciences · R01 · FY2025 · AI
CPML - Core C: Bioinformatics & Biostatistical Core
$596,873Jinghui Zhang · St. Jude Children'S Research Hospital · P50 · FY2019 · GM
CPML - Core C: Bioinformatics & Biostatistical Core
$596,871Jinghui Zhang · St. Jude Children'S Research Hospital · P50 · FY2016 · GM
CPML - Core C: Bioinformatics & Biostatistical Core
$596,871Jinghui Zhang · St. Jude Children'S Research Hospital · P50 · FY2017 · GM
Hematopathology Fellowship
$596,786Elaine Jaffe · Division Of Basic Sciences - Nci · ZIE · FY2015 · CA
Optimizing prognostic and predictive algorithms using residual disease (RD) genomic biomarkers in HER2+ and TNBC
$596,748Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$596,741Susan L Slager · Mayo Clinic Rochester · U01 · FY2015 · CA
Validation of Decision Rules for CT Use in Children with Abdominal or Head Trauma
$596,664James F Holmes · University Of California At Davis · R01 · FY2020 · HD
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$596,600Joseph C Wu · Stanford University · R01 · FY2018 · HL